Recurrent Neural Network-based Model Predictive Control for Continuous Pharmaceutical Manufacturing
For the pharmaceutical industry, this work provides a practical data-driven modeling alternative to physics-based models for MPC in continuous manufacturing, addressing the challenge of complex reaction kinetics.
The paper demonstrates that Recurrent Neural Networks (RNNs) can be effectively used for Model Predictive Control (MPC) in continuous pharmaceutical manufacturing, achieving satisfactory closed-loop control performance for regulating critical quality attributes.
The pharmaceutical industry has witnessed exponential growth in transforming operations towards continuous manufacturing to effectively achieve increased profitability, reduced waste, and extended product range. Model Predictive Control (MPC) can be applied for enabling this vision, in providing superior regulation of critical quality attributes. For MPC, obtaining a workable model is of fundamental importance, especially in the presence of complex reaction kinetics and process dynamics. Whilst physics-based models are desirable, it is not always practical to obtain one effective and fit-for-purpose model. Instead, within industry, data-driven system-identification approaches have been found to be useful and widely deployed in MPC solutions. In this work, we demonstrated the applicability of Recurrent Neural Networks (RNNs) for MPC applications in continuous pharmaceutical manufacturing. We have shown that RNNs are especially well-suited for modeling dynamical systems due to their mathematical structure and satisfactory closed-loop control performance can be yielded for MPC in continuous pharmaceutical manufacturing.